Allos Therapeutics, Inc. (NASDAQ:ALTH) witnessed volume of 5.15 million shares during last trade however it holds an average trading capacity of 1.82 million shares. ALTH last trade opened at $1.82 reached intraday low of $1.73 and went -1.64% down to close at $1.80.
ALTH has a market capitalization $190.10 million and an enterprise value at $110.69 million. Trailing twelve months price to sales ratio of the stock was 5.00 while price to book ratio in most recent quarter was 2.23. In profitability ratios, net profit margin in past twelve months appeared at -186.31% whereas operating profit margin for the same period at -190.93%.
The company made a return on asset of -35.22% in past twelve months and return on equity of -62.41% for similar period. In the period of trailing 12 months it generated revenue amounted to $38.68 million gaining $0.37 revenue per share. Its year over year, quarterly growth of revenue was 46.70%.
According to preceding quarter balance sheet results, the company had $79.42 million cash in hand making cash per share at 0.75. The total of $0.00 billion debt. Moreover its current ratio according to same quarter results was 5.76 and book value per share was 0.82.
Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated 21.98% where the stock current price exhibited down beat from its 50 day moving average price of $2.05 and remained below from its 200 Day Moving Average price of $2.85.
ALTH holds 105.61 million outstanding shares with 68.47 million floating shares where insider possessed 1.55% and institutions kept 97.80%.
No comments:
Post a Comment